Evidence‑Based Recommendations for Diagnosing Insomnia Disorder

Diagnostic Frameworks

The DSM‑5‑TR offers a streamlined, clinically practical diagnostic framework that emphasizes functional impairment and is well‑suited for psychiatric practice settings, as endorsed by the American Academy of Sleep Medicine (AASM). [1][2]
The ICD‑11 provides a globally applicable classification system that ensures consistent diagnostic coding across health‑care systems worldwide for epidemiological tracking and resource allocation, as defined by the World Health Organization (WHO). 6

Clear quantitative thresholds – Insomnia is defined as occurring ≥ 3 nights per week for ≥ 3 months, reducing diagnostic variability and improving inter‑rater reliability. [1][2]
Requirement of daytime impairment – Diagnosis mandates documentation of clinically significant distress or impairment in social, occupational, educational, or behavioral functioning, ensuring that only clinically meaningful cases are captured. [1][2]
Emphasis on functional impairment – The framework focuses on functional consequences rather than solely on symptom count, aligning with psychiatric practice needs. [1][2]

Limited phenotypic specificity – The criteria do not differentiate sleep‑onset, sleep‑maintenance, or early‑morning awakening subtypes, which have distinct treatment implications. [4][5]
Absence of standardized severity gradations – No formal mild, moderate, or severe ratings are provided based on frequency of affected nights or degree of daytime impairment. [1][2]
Minimal assessment of perpetuating factors – The diagnostic system does not systematically evaluate maladaptive sleep behaviors, dysfunctional beliefs about sleep, or conditioned arousal, all of which are key targets for cognitive‑behavioral therapy for insomnia (CBT‑I). [4][5]

International standardization – Adopted by WHO member states from January 2022, enabling uniform coding for morbidity and mortality statistics worldwide. 6
Harmonization with DSM‑5 – Collaborative alignment with the American Psychiatric Association reduces diagnostic discordance between the two major classification systems. 6
Dedicated sleep‑wake disorders chapter – A separate chapter improves visibility of sleep disorders and facilitates multidisciplinary care. 6
Developmental continuity – Eliminates a separate “disorders with onset in childhood/adolescence” category, recognizing insomnia’s continuity across the lifespan. 6
Incorporation of dimensional elements – Introduces a stepwise diagnostic approach that blends categorical and dimensional assessments, potentially enhancing clinical utility. 6

Conservative evolution from ICD‑10 – Retains a predominantly categorical, symptom‑based structure without integrating neurobiology‑based or hierarchical classification paradigms. 6
Limited insomnia‑specific detail – Lacks the granular subtyping found in the International Classification of Sleep Disorders (ICSD‑2), which delineates 12 distinct insomnia disorders. [4][1]2
Insufficient integration with sleep‑medicine nosology – Does not capture ICSD‑2 categories such as psychophysiological, paradoxical, idiopathic insomnia, or inadequate sleep hygiene. [4][1]

Apply DSM‑5‑TR criteria (≥ 3 nights/week for ≥ 3 months plus documented daytime impairment) for initial diagnosis and insurance coding; this aligns with evidence‑based guidelines that recommend CBT‑I as the first‑line treatment for chronic insomnia. [1][2]

Utilize ICSD‑2 subtypes (e.g., psychophysiological, paradoxical, idiopathic, insomnia due to mental disorder, medical condition, drug/substance, or inadequate sleep hygiene) to tailor specific behavioral and pharmacological interventions. [4][1]5

Employ ICD‑11 coding for cross‑national prevalence studies and health‑resource planning, leveraging its status as the global standard for morbidity and mortality statistics. 6

Neglect of insomnia phenotypes – Failure to distinguish sleep‑onset, sleep‑maintenance, and early‑morning awakening patterns can lead to suboptimal pharmacologic choices (e.g., onset‑targeted agents vs. maintenance‑targeted agents). [4][5]
Overlooking perpetuating factors – Not assessing maladaptive behaviors (e.g., excessive time in bed), dysfunctional cognitions (e.g., “I must get 8 h or I’ll be ruined”), or conditioned arousal hampers effective CBT‑I planning. [4][5]
Ignoring objective‑subjective discordance – Paradoxical insomnia (severe subjective complaint with minimal objective disturbance) requires different management than psychophysiological insomnia, yet neither DSM‑5‑TR nor ICD‑11 differentiate these presentations. [4][1]
Premature diagnosis without adequate assessment – A minimum 2‑week sleep diary documenting bedtime, sleep latency, number and duration of awakenings, wake after sleep onset, time in bed, total sleep time, and sleep efficiency should be obtained before confirming an insomnia diagnosis. [1][5]
Missing comorbid sleep disorders – Persistent insomnia beyond 7–10 days of treatment warrants evaluation for obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder, or circadian‑rhythm disorders, which are listed separately but frequently co‑occur. [5][7]